NCT04656886View on ClinicalTrials.gov

Ketamine's Actions on Rumination Mechanisms as an Antidepressant

NACompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions

Remission in Depression

Interventions

DRUG

Intravenous Infusion

Sponsors

Collaborators (1)

Johnson & Johnson

All Listed Sponsors

collaborator

Johnson & Johnson

INDUSTRY

lead

King's College London

OTHER